Evidence map›Paper›PMID 37502976›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Allelic strengths of encephalopathy-associated

Xueyang Pan, Albert N Alvarez, Mengqi Ma, Shenzhao Lu, Michael W Crawford, Lauren C Briere, Oguz Kanca, Shinya Yamamoto, David A Sweetser, Jenny L Wilson and 3 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xueyang PanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Albert N AlvarezDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
Mengqi MaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Shenzhao LuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Michael W CrawfordDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
Lauren C BriereCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Oguz KancaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Shinya YamamotoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
David A SweetserCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Jenny L WilsonDivision of Pediatric Neurology, Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA.
Ruth J NapierDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
Jonathan N PrunedaDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Baylor College of Medicine · USOregon Health & Science University · USMassachusetts General Hospital · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Resource and Service SectionU54OD030165 · OD · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney · 2020 to 2026
$16.6M
Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Sandesh Chakravarthy Sreenath Nagamani, David Loren Nelson · 2020 to 2026
$9.9M
Expansion and characterization of the Drosophila Toolkit to study SARS-CoV-2R24OD022005 · OD · BAYLOR COLLEGE OF MEDICINE · PI BELLEN, HUGO J · 2016 to 2023
$7.4M
A Comprehensive Resource for Manipulating the Drosophila GenomeR24OD031447 · OD · BAYLOR COLLEGE OF MEDICINE · PI HUGO J BELLEN, Oguz Kanca · 2021 to 2026
$5.2M
Exploiting bacterial effector proteins to study human ubiquitin signalingR35GM142486 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jonathan N Pruneda · 2021 to 2026
$2.6M
Reprogramming T Cells in Rheumatoid ArthritisIK2BX004523 · VA · PORTLAND VA MEDICAL CENTER · PI NAPIER, RUTH · 2019 to 2023
–
BLRD VA IK2 BX004523NCATS NIH HHS UL1 TR002369NHGRI NIH HHS U01 HG007690NICHD NIH HHS P50 HD103555NIGMS NIH HHS R35 GM142486NIH HHS R24 OD022005NIH HHS R24 OD031447NIH HHS U54 OD030165
6 · The paper itself

Abstract

Protein UFMylation downstream of the E1 enzyme UBA5 plays essential roles in development and ER stress. Variants in the

Identifiers

PMID37502976
PMCPMC10371176
OpenAlexW4385164003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.